Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Trends Pharmacol Sci. 2010 Dec 1;31(12):596–604. doi: 10.1016/j.tips.2010.09.005

Table 1.

Multipotential drugs for TBI

Multipotential drug Targeted secondary injury mechanism Reference

Statins Excitotoxicity [28]
Apoptosis [30, 32]
Inflammation [27, 35, 36]
Edema [27, 35]
BBB disruption [35]

Progesterone Excitotoxicity [46]
Apoptosis [4749]
Oxidative stress [50]
Inflammation [52, 53]
Edema [49, 54]

Cyclosporine A Mitochondrial dysfunction [64, 66, 70, 71]
Calpain activation [67, 71]
Apoptosis [64]
Oxidative stress [71, 72]

Diketopiperazine Apoptosis [76, 77, 80]
Calpain and cathepsin activation [76, 79]
Inflammation [80]

Cell cycle inhibitors Apoptosis [8891]
Inflammation [87, 88, 91]

PARP inhibitors Apoptosis [103]
Inflammation [104106]